Emmes

In rare disease research, every patient counts. A truly patient-first approach can be the difference between a successful trial and one that struggles due to recruitment and retention challenges. With smaller patient populations, rare disease trials face unique hurdles—from slow recruitment and under-enrollment to difficulty retaining participants. Having the right strategies in place is critical to keeping your trial on track. Our infographic, “Path to a Successful Rare Disease Trial,” breaks down the key recruitment and retention strategies you need to succeed. Check it out! ?? Visit the link to learn more: https://hubs.la/Q038-RGT0 #RareDisease #ClinicalTrials #PatientCentric

Today is #RareDiseaseDay. Today, it’s essential to consider the impact of every rare disease clinical trial. With delayed diagnoses and limited treatment options, rare disease patients and caregivers navigate immense challenges in their search for effective solutions and support. We stand with the rare disease community today and every day, working to advance clinical trials that bring innovative solutions to patients who need them most. Explore how we’re driving innovation in rare disease clinical trials by visiting our website: https://hubs.la/Q038GZ630 #RareDiseaseDay #EmmesGroup #ClinicalResearch #HealthcareInnovation #TogetherForRare #RaiseAwareness #RaisingHope

As we approach #RareDiseaseDay2025, we would like to take the opportunity to showcase our unwavering support for the rare disease community. Emmes stands united in raising awareness for the 300 million people worldwide living with rare diseases, along with their families and caregivers. As a trusted partner in rare disease clinical research, we are committed to improving rare disease patient outcomes and driving change through innovation and collaboration. Join us in supporting this vital cause. Together, we can make a difference! Visit our website to learn more about our commitment to rare disease research and how we're working to create a healthier future for all - https://lnkd.in/geWzHikC #RareDiseaseDay #EmmesGroup #ClinicalResearch #HealthcareInnovation #TogetherForRare #RaiseAwareness #RaisingHope

Join Our Team at Emmes! We are actively looking for a Senior Clinical Research Associate to join our team of passionate professionals dedicated to advancing global health! If you’re driven by innovation and looking for a meaningful career, we want to hear from you. Learn more at: https://emmes.com/careers #JobOpening #ClinicalResearch #ClinicalResearchAssociate #JoinOurTeam #GlobalHealth #CareerOpportunity #Emmes #CRA

Traditional drug development doesn’t often fit the needs of rare disease patients. With the rise of precision medicine, tailored treatments are offering new hope. Discover how personalized medicine is transforming rare disease trials and gain insights from the rare disease community on the evolving research landscape in our whitepaper “Thinking of the Individual in Rare Disease Clinical Trials”: https://lnkd.in/eRkSGyJw #PersonalisedMedicine #RareDiseaseDay2025 #RareDiseaseAdvocacy #PatientFocused #Emmes #CRO

Watch another part of Peter Ronco's interview at #SCOPE, where he shares insightful advice on scaling clinical programs for small biopharma companies, with Don Tracy, Associate Editor of Applied Clinical Trials Magazine. > Build a strong core team: Project Manager, Statistician, and MD Support. > Partner with providers who can grow with you. Watch the full interview for more expert tips! ?? https://lnkd.in/eccSykfq #biopharma #clinicaltrials #Emmes #PeterRonco #pharmascience #BiotechPartnerships #ClinicalTrialInsights #EmmesGroup #CRO?

In part 3 of our CGT trials video series, we focus on minimizing patient burden. With intense trials and patients who've often undergone multiple treatments, it's crucial that only necessary procedures are conducted to gather the right data. As the longest-standing CGT-specialized CRO, with 125+ trials in 35 years, we understand the importance of trial design, patient recruitment, and site selection. At Emmes, we're committed to advancing medicine through clinical research for years to come. Watch the video now! #CGT #ClinicalTrials #PatientBurden #GeneTherapy #CellTherapy #ResearchAdvancement #Emmes #CRO #EmmesGroup

As the industry's longest-standing cell and gene therapy (CGT) specialized CRO, with 125+ CGT trials conducted over the past 35 years, Emmes Group knows the importance of getting trial design right. With a limited patient population, site selection and patient recruitment become critical for visibility and success. Beyond that, when FDA guidance is unavailable, the project team must carefully consider all factors to determine the best approach for answering the clinical question. We are committed to advancing clinical research and being a trusted partner in the CGT field for years to come. Watch the video to learn more! #CGT #CellAndGeneTherapy #ClinicalTrials #CRO #EmmesGroup #Innovation #TrialDesign

Emmes Group is proud to announce that we’ve achieved ISO/IEC 27001:2022 certification, the gold standard for data security! This accreditation highlights our commitment to safeguarding sensitive information and advancing secure, data-driven trials for our biotech and pharma partners. With AI and advanced analytics transforming clinical research, data security is more critical than ever. Read the full press release here: https://lnkd.in/gUkzaBPY #DataSecurity #ISO27001 #ClinicalTrials #EmmesGroup #Pharma #Biotech #AI #Innovation #ClinicalResearch #DataProtection #InformationSecurity #Certification

In an interview with ACT’s Don Tracy, Peter Ronco, Emmes CEO, shares insights from the “Choosing the Right Allies” session, highlighting the Goldilocks principle—finding a partner that’s the right size to deliver results with personalized attention. He also emphasizes transparency and collaboration for overcoming challenges in clinical trials. Interested in more insights? Watch the rest of the interview to learn how small biotechs can select the right partners for success! https://lnkd.in/efr5xCq5 #ClinicalTrials #Biopharma #SmallBiotech #Partnerships #Emmes #CRO #EmmesGroup #TransparencyInTrials #CollaborationInBiotech #BiotechIndustry #BiotechPartnerships